These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31941971)

  • 1. Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Kim JH; Kim JW; Kim CG; Lee DW
    Sci Rep; 2020 Jan; 10(1):359. PubMed ID: 31941971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of vitrectomy for breakthrough vitreous hemorrhage associated with age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jung JH; Lee JK; Lee JE; Oum BS
    Retina; 2010 Jun; 30(6):865-73. PubMed ID: 20182402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors and Long-term Surgical Outcomes for Exudative Age-related Macular Degeneration with Breakthrough Vitreous Hemorrhage.
    Kim TY; Kang HG; Choi EY; Koh HJ; Kim SS; Lee JH; Kim M; Byeon SH; Lee CS
    Korean J Ophthalmol; 2020 Aug; 34(4):281-289. PubMed ID: 32783420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THE INCIDENCE, CHARACTERISTICS, MANAGEMENT, PROGNOSIS, AND CLASSIFICATION OF BREAKTHROUGH VITREOUS HEMORRHAGE SECONDARY TO POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Zhao XY; Luo MY; Meng LH; Zhang WF; Li B; Wang EQ; Liu SZ; Yu WH; Chen YX
    Retina; 2021 Aug; 41(8):1675-1685. PubMed ID: 33395221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration.
    Iwase T; Baba T; Saito Y; Nizawa T; Yokouchi H; Kubota-Taniai M; Kitahashi M; Yamamoto S
    Int Ophthalmol; 2021 May; 41(5):1835-1844. PubMed ID: 33611763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual outcomes of early and late vitrectomy for breakthrough vitreous hemorrhage associated with exudative age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Khongsakdinasarn N; Ratanasukon M; Bhurayanontachai P; Dangboon Tsutsumi W
    Medicine (Baltimore); 2023 Oct; 102(40):e35364. PubMed ID: 37800778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term results after simple vitrectomy for age-related macular degeneration with vitreous hemorrhage].
    Gomi F; Emi K; Motokura M; Oshima Y; Yamanishi S
    Nippon Ganka Gakkai Zasshi; 1998 Jul; 102(7):436-41. PubMed ID: 9720365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of vitreous hemorrhage after photodynamic therapy for age-related macular degeneration].
    Ogino T; Takeda M; Imaizumi H; Okushiba U
    Nippon Ganka Gakkai Zasshi; 2009 Apr; 113(4):498-504. PubMed ID: 19455971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cataract surgery and vitrectomy for breakthrough vitreous hemorrhage from age-related macular degeneration.
    Chaudhry NA; Flynn HW; Murray TG; Belfort A
    Ophthalmic Surg Lasers; 2002; 33(1):16-8. PubMed ID: 11820658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitrectomy for treatment of vitreous hemorrhage associated with age-related macular degeneration].
    Li G; Gao R
    Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):262-3. PubMed ID: 8745517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J; Lee JH; Jung BJ; Kook L; Lee WK
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Takahashi Y; Koizumi H; Hasegawa T; Izumi T; Maruko I; Sonoda S; Sakamoto T; Iida T
    Jpn J Ophthalmol; 2018 Sep; 62(5):576-583. PubMed ID: 30069649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration.
    Hasegawa T; Otani A; Sasahara M; Gotoh N; Ooto S; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2010 Feb; 149(2):322-329.e1. PubMed ID: 20103057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy.
    Kimura S; Morizane Y; Hosokawa MM; Shiode Y; Doi S; Hosogi M; Fujiwara A; Okanouchi T; Inoue Y; Shiraga F
    Jpn J Ophthalmol; 2019 Sep; 63(5):382-388. PubMed ID: 31243593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.
    Li MS; Tsen CL
    PLoS One; 2022; 17(12):e0279778. PubMed ID: 36584198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrectomy for exudative age-related macular degeneration with vitreous hemorrhage.
    Sakamoto T; Sheu SJ; Arimura N; Sameshima S; Shimura M; Uemura A; Kawano H; Wu TT; Kubota T; Sohma R; Noda Y
    Retina; 2010 Jun; 30(6):856-64. PubMed ID: 20182401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundus autofluorescence in polypoidal choroidal vasculopathy.
    Yamagishi T; Koizumi H; Yamazaki T; Kinoshita S
    Ophthalmology; 2012 Aug; 119(8):1650-7. PubMed ID: 22512987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Anti-Vascular Endothelial Growth Factor Drugs Before and After Pars Plana Vitrectomy in Patients with Polypoidal Choroidal Vasculopathy and Vitreous Hemorrhage.
    Chen L; Qu L; Gui Q; Wang S; Mao J; Fu X; Li W; Wang Y; Yi Q
    J Ocul Pharmacol Ther; 2021 Dec; 37(10):591-596. PubMed ID: 34678098
    [No Abstract]   [Full Text] [Related]  

  • 19. Polypoidal choroidal vasculopathy in Taiwanese patients.
    Chang YC; Wu WC
    Ophthalmic Surg Lasers Imaging; 2009; 40(6):576-81. PubMed ID: 19928723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy.
    Ogasawara M; Koizumi H; Yamamoto A; Itagaki K; Saito M; Maruko I; Okada AA; Iida T; Sekiryu T
    Jpn J Ophthalmol; 2018 Sep; 62(5):584-591. PubMed ID: 29974277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.